lrinotecan Market Report Opportunities, and Forecast By 2033
(0 User reviews)
125
74
I am Manjeet Ahirwar. I hold full responsibility for this content, which includes text, images, links, and files. The website administrator and team cannot be held accountable for this content. If there is anything you need to discuss, you can reach out to me via yogesh@marketstatsville.com email.
Disclaimer: The domain owner, admin and website staff of PDF24x7, had no role in the preparation of this post. PDF24x7, does not accept liability for any loss or damages caused by the use of any links, images, texts, files, or products, nor do we endorse any content posted in this website.
Abstract
According to the Market Statsville Group (MSG), the Global lrinotecan Market size is expected to grow at a CAGR of 6.1% from 2023 to 2033.
Camptosar, also known as irinotecan, is a drug used in the treatment of cancers of the colon and the lungs. It can be used alone or in combination with fluorouracil to treat colon cancer. It is used with cisplatin to treat small cell lung cancer. Irinotecan is injected intravenously (into a vein) by a doctor or nurse during a 90-minute period. Irinotecan works as a topoisomerase I inhibitor. It operates by decreasing the action of topoisomerase I, an enzyme involved in DNA replication and repair. Irinotecan prevents the unwinding of DNA strands, resulting in DNA damage and eventually reducing the proliferation of cancer cells by blocking this enzyme.
According to the Market Statsville Group (MSG), the Global lrinotecan Market size is expected to grow at a CAGR of 6.1% from 2023 to 2033.
Camptosar, also known as irinotecan, is a drug used in the treatment of cancers of the colon and the lungs. It can be used alone or in combination with fluorouracil to treat colon cancer. It is used with cisplatin to treat small cell lung cancer. Irinotecan is injected intravenously (into a vein) by a doctor or nurse during a 90-minute period. Irinotecan works as a topoisomerase I inhibitor. It operates by decreasing the action of topoisomerase I, an enzyme involved in DNA replication and repair. Irinotecan prevents the unwinding of DNA strands, resulting in DNA damage and eventually reducing the proliferation of cancer cells by blocking this enzyme.
There are no reviews for this PDF.
There are no comments for this PDF.
You must log in to post a comment.
Log in
